Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 7:22 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.6% | -925,000 (-18.28%) | View |
| 2022-02-04 09:12 am Sale | 13G | MERUS N V COM MRUS | WELLINGTON MANAGEMENT GROUP LLP | 3,154,551 7.39% | -1,445,807 (-31.43%) | View |
| 2021-08-10 07:57 am Purchase | 13G | MERUS N V COM MRUS | WELLINGTON MANAGEMENT GROUP LLP | 4,600,358 12% | 3,470,723 (+307.24%) | View |
| 2021-07-07 4:35 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.2% | -745,500 (-12.84%) | View |
| 2021-02-12 4:16 pm Purchase | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,805,571 19.96% | 815,000 (+16.33%) | View |
| 2021-02-12 3:52 pm Sale | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 0 0% | -1,906,861 (Position Closed) | View |
| 2021-02-12 12:46 pm Unchanged | 13G | MERUS N V COM MRUS | FEDERATED HERMES INC. FHI | 2,936,798 10.1% | 0 (Unchanged) | View |
| 2021-02-11 08:41 am Unchanged | 13G | MERUS N V COM MRUS | Medicxi Growth I LP | 1,600,000 4.3% | 0 (Unchanged) | View |
| 2021-01-25 4:08 pm Purchase | 13D | MERUS N V COM MRUS | INCYTE CORP INCY | 3,550,000 9.4% | 350,000 (+10.94%) | View |
| 2021-01-20 4:31 pm Purchase | 13G | MERUS N V COM MRUS | Boxer Capital LLC | 1,600,000 5.5% | 1,600,000 (New Position) | View |
| 2020-12-28 4:08 pm Unchanged | 13D | MERUS N V COM MRUS | INCYTE CORP INCY | 3,200,000 11% | 0 (Unchanged) | View |
| 2020-11-10 12:58 pm Purchase | 13G | MERUS N V COM MRUS | FEDERATED HERMES INC. FHI | 2,936,798 10.11% | 2,936,798 (New Position) | View |
| 2020-06-03 5:03 pm Purchase | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,990,571 17.2% | 1,820,917 (+57.45%) | View |
| 2020-04-27 1:04 pm Sale | 13D | MERUS N V COM MRUS | Sofinnova Venture Partners IX L.P. | 1,311,039 4.5% | -439,060 (-25.09%) | View |
| 2020-04-24 4:35 pm Purchase | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 1,906,861 6.6% | 188,661 (+10.98%) | View |
| 2020-02-14 4:14 pm Purchase | 13G | MERUS N V COM MRUS | BAKER BROS. ADVISORS LP | 2,037,469 7.1% | 877,455 (+75.64%) | View |
| 2020-02-14 3:03 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 3,169,654 11% | -173,759 (-5.20%) | View |
| 2020-02-14 2:34 pm Purchase | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 1,718,200 6% | 1,718,200 (New Position) | View |
| 2020-02-13 8:06 pm Sale | 13G | MERUS N V COM MRUS | Aquilo Capital Management LLC | 1,038,746 3.6% | -442,109 (-29.85%) | View |
| 2019-11-14 11:03 am Purchase | 13G | MERUS N V COM MRUS | Medicxi Growth I LP | 1,600,000 5.5% | 1,600,000 (New Position) | View |